GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Dementia Risk After 90: New Study Shows Why We're Never In the Clear
It is a common and comforting assumption: if you or your loved ones can make it to 90 years old with a sharp mind, you have somehow beaten the odds. We tend to think that after a certain milestone, the risk of cognitive decline plateaus, and we can finally breathe a sigh of relief.
The U.S. POINTER Trial: Outrunning Cognitive Decline
Enter the U.S. POINTER Trial, a massive, multiyear clinical study designed to answer one definitive question: Can structured lifestyle changes protect our brains as we age? The results are in, and they are the ultimate dose of medical empowerment.